Zhenqiang Gao

503 total citations
26 papers, 344 citations indexed

About

Zhenqiang Gao is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Zhenqiang Gao has authored 26 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Zhenqiang Gao's work include Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), RNA and protein synthesis mechanisms (3 papers) and RNA modifications and cancer (3 papers). Zhenqiang Gao is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), RNA and protein synthesis mechanisms (3 papers) and RNA modifications and cancer (3 papers). Zhenqiang Gao collaborates with scholars based in China, United States and Vietnam. Zhenqiang Gao's co-authors include Yuanyuan Zheng, Yan Meng, Bruce M. Boman, Xiyu Zhang, Ramona Graves‐Deal, Nathan S. Cutler, Erin Terry, Bonnie LaFleur, Robert J. Coffey and Jason D. Morrow and has published in prestigious journals such as International Journal of Cancer, Biochemical Pharmacology and Advanced Science.

In The Last Decade

Zhenqiang Gao

24 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenqiang Gao China 10 155 96 83 67 46 26 344
Altay Burak Dalan Türkiye 13 154 1.0× 54 0.6× 98 1.2× 63 0.9× 39 0.8× 33 383
Masahiro Shiba Japan 10 181 1.2× 65 0.7× 88 1.1× 91 1.4× 55 1.2× 37 448
Jinna Wu China 9 128 0.8× 61 0.6× 57 0.7× 54 0.8× 45 1.0× 18 327
Tania Tsatralis Australia 10 191 1.2× 34 0.4× 79 1.0× 40 0.6× 52 1.1× 11 335
Xinan Wang China 11 189 1.2× 47 0.5× 82 1.0× 54 0.8× 24 0.5× 35 384
Sheng Hu China 9 143 0.9× 52 0.5× 43 0.5× 76 1.1× 52 1.1× 28 331
Ruifeng Shi China 14 233 1.5× 130 1.4× 105 1.3× 100 1.5× 34 0.7× 46 493
Hui Jun Lim Singapore 10 273 1.8× 86 0.9× 97 1.2× 149 2.2× 58 1.3× 26 497
Pengcheng Luo China 12 152 1.0× 82 0.9× 77 0.9× 70 1.0× 37 0.8× 26 351
Atsunobu Sagara Japan 9 137 0.9× 73 0.8× 36 0.4× 80 1.2× 40 0.9× 22 322

Countries citing papers authored by Zhenqiang Gao

Since Specialization
Citations

This map shows the geographic impact of Zhenqiang Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenqiang Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenqiang Gao more than expected).

Fields of papers citing papers by Zhenqiang Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenqiang Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenqiang Gao. The network helps show where Zhenqiang Gao may publish in the future.

Co-authorship network of co-authors of Zhenqiang Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenqiang Gao. A scholar is included among the top collaborators of Zhenqiang Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenqiang Gao. Zhenqiang Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Yan, Xiyu Zhang, Zhenqiang Gao, et al.. (2025). xCT/Slc7a11 promotes pulmonary arterial hypertension by disrupting AMPKα suppression of mTOR activation. Biochemical Pharmacology. 236. 116897–116897.
2.
Guo, Yu, Zhenqiang Gao, Zhe An, et al.. (2025). Neutrophil–Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension. Advanced Science. 12(31). e04397–e04397. 1 indexed citations
3.
Gao, Zhenqiang, Yaqi Xing, Xiyu Zhang, et al.. (2023). Polo-like kinase 1 promotes sepsis-induced myocardial dysfunction. International Immunopharmacology. 125(Pt A). 111074–111074. 6 indexed citations
4.
Xing, Yaqi, Zhenqiang Gao, Yunfei Bai, et al.. (2023). Golgi Protein 73 Promotes LPS-Induced Cardiac Dysfunction via Mediating Myocardial Apoptosis and Autophagy. Journal of Cardiovascular Pharmacology. 83(1). 116–125. 10 indexed citations
5.
Chen, Chen, et al.. (2022). Sulfasalazine exacerbates angiotensin II‐induced cardiac remodelling by activating Akt signal pathway. Clinical and Experimental Pharmacology and Physiology. 49(7). 776–783. 1 indexed citations
6.
Zhang, Xiyu, Zhenqiang Gao, Lingling Wang, et al.. (2021). PKM2 promotes angiotensin‐II‐induced cardiac remodelling by activating TGF‐β/Smad2/3 and Jak2/Stat3 pathways through oxidative stress. Journal of Cellular and Molecular Medicine. 25(22). 10711–10723. 46 indexed citations
7.
Zhang, Xiyu, Zhenqiang Gao, Hongyu Chen, et al.. (2021). SLC7A11/xCT Prevents Cardiac Hypertrophy by Inhibiting Ferroptosis. Cardiovascular Drugs and Therapy. 36(3). 437–447. 79 indexed citations
8.
McGettigan, Melissa, Christine O. Menias, Zhenqiang Gao, Vincent M. Mellnick, & Amy K. Hara. (2016). Imaging of Drug-induced Complications in the Gastrointestinal System. Radiographics. 36(1). 71–87. 23 indexed citations
9.
10.
Gao, Zhenqiang, et al.. (2007). Plexiform Epithelioid Schwannoma:. American Journal of Dermatopathology. 29(1). 56–58. 10 indexed citations
11.
Jalal, Prasun K., et al.. (2006). Gastric heterotopia in the rectum. Gastrointestinal Endoscopy. 63(7). 1075–1076. 3 indexed citations
12.
Gao, Zhenqiang, Leonard B. Kahn, & Tawfiqul Bhuiya. (2006). Thymic carcinoid with mucinous stroma: a rare variant of carcinoid with an aggressive clinical course. Annals of Diagnostic Pathology. 10(2). 114–116. 1 indexed citations
13.
Rudloff, Udo, Zhenqiang Gao, Scott Fields, & Gary Gecelter. (2005). Osteoclast-like giant cell tumor of the liver: a rare neoplasm with an aggressive clinical course. Journal of Gastrointestinal Surgery. 9(2). 207–214. 16 indexed citations
14.
Gao, Zhenqiang & Leonard B. Kahn. (2005). The application of immunohistochemistry in the diagnosis of bone tumors and tumor-like lesions. Skeletal Radiology. 34(12). 755–770. 9 indexed citations
15.
Fields, Jeremy Z., Zhenqiang Gao, Marcia Lewis, et al.. (2004). Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer. Journal of Laboratory and Clinical Medicine. 143(1). 59–66. 1 indexed citations
16.
Li, Xinming, Steven H. Seeholzer, Tao Zhang, et al.. (2004). Analyzing Alkaline Proteins in Human Colon Crypt Proteome. Journal of Proteome Research. 3(4). 821–833. 18 indexed citations
17.
Gao, Zhenqiang, et al.. (1999). Tumor‐specific expression of anti‐ mdr1 ribozyme selectively restores chemosensitivity in multidrug‐resistant colon‐adenocarcinoma cells. International Journal of Cancer. 82(3). 346–352. 27 indexed citations
18.
Gao, Zhenqiang, et al.. (1997). Chemotherapy of multidrug-resistant human lung cancer combined with an MDR1 ribozyme retroviral vector in an orthotopic model. Chinese Science Bulletin. 42(3). 231–234. 1 indexed citations
19.
Gao, Zhenqiang, et al.. (1997). Selective reversal of drug resistance in drug-resistant lung adenocarcinoma cells by tumor-specific expression of mdrl ribozyme gene mediated by retrovirus. Science in China Series C Life Sciences. 40(2). 122–127. 2 indexed citations
20.
Gao, Zhenqiang, et al.. (1997). Increasing drug resistance in human lung cancer cells by mutant-type p53 gene mediated by retrovirus. Science in China Series C Life Sciences. 40(1). 101–106. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Altay Burak Dalan Breakdown of academic impact, for papers by Masahiro Shiba Breakdown of academic impact, for papers by Jinna Wu Breakdown of academic impact, for papers by Tania Tsatralis Breakdown of academic impact, for papers by Xinan Wang Breakdown of academic impact, for papers by Sheng Hu Breakdown of academic impact, for papers by Ruifeng Shi Breakdown of academic impact, for papers by Hui Jun Lim Breakdown of academic impact, for papers by Pengcheng Luo Breakdown of academic impact, for papers by Atsunobu Sagara
Rankless by CCL
2026